文献速递膀胱癌与上尿路尿路上皮癌

非肌层浸润性膀胱癌经尿道切除后即刻灌注丝裂霉素C时机对复发时间的影响

The effect of timing of an immediate instillation of mitomycin C after transurethral resection in 941 patients with non-muscle-invasive bladder cancer.
PubMed 文献 · BJU Int · 2018-01-31

该研究纳入1998至2003年前瞻性试验中941例非肌层浸润性膀胱癌患者,比较经尿道膀胱肿瘤电切术当天与术后1天灌注丝裂霉素C对复发时间的影响。结果显示两组复发时间无统计学显著差异(log-rank P=0.99),校正辅助灌注次数后风险比1.05(95%CI 0.81-1.35,P=0.74)。结论不支持术当天极早期灌注优于术后1天灌注。

要点

  • 术当天与术后1天灌注丝裂霉素C的复发时间无显著差异(log-rank P=0.99)。
  • 校正辅助灌注次数后风险比1.05(95%CI 0.81-1.35,P=0.74)。
  • 数据不支持术当天极早期灌注较术后1天灌注降低复发风险。

核心结论

  • 术当天灌注丝裂霉素C与术后1天灌注相比,未显著改善非肌层浸润性膀胱癌的复发时间。

研究设计与样本

  • 选取1998至2003年前瞻性试验中941例非肌层浸润性膀胱癌患者,均接受早期丝裂霉素C灌注(术当天或术后1天)。
  • 采用Kaplan-Meier曲线和多变量Cox回归进行统计分析。

主要发现

  • 单变量模型中,术当天与术后1天灌注的复发时间无统计学显著差异(log-rank P=0.99)。
  • 校正计划辅助灌注次数后,风险比1.05(95%CI 0.81-1.35,P=0.74),仍无显著差异。

关键数值与推荐

  • 复发时间比较的log-rank P=0.99。
  • 校正辅助灌注次数后的风险比1.05(95%CI 0.81-1.35,P=0.74)。

临床怎么用

  • 临床中术当天或术后1天灌注丝裂霉素C均可接受,无需强调术当天极早期灌注以降低复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether the timing of an immediate instillation of mitomycin C (on the day of transurethral resection of bladder tumour [TURBT] or 1 day later) has an impact on time to recurrence of non-muscle-invasive bladder cancer (NMIBC). PATIENTS AND METHODS: All patients with NMIBC who were enrolled in a prospective trial between 1998 and 2003, and treated with an early mitomycin C instillation (on the day of TURBT or 1 day later), were selected. Statistical analysis was performed with Kaplan-Meier curves and multivariable Cox regression. RESULTS: Administering an instillation of mitomycin C on the day of TURBT or 1 day later did not show a statistically significant difference in time to recurrence in a univariable model (log-rank P = 0.99). After correcting for the number of scheduled adjuvant instillations, no statistically significant difference could be detected either: hazard ratio 1.05 (95% confidence interval 0.81-1.35, P = 0.74). CONCLUSION: These data do not support the hypothesis that a very early instillation (on the day of TURBT) of mitomycin C decreases the risk of recurrence as compared with an early instillation (1 day after TURBT).

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Bosschieter J, van Moorselaar RJA, Vis AN, et al. The effect of timing of an immediate instillation of mitomycin C after transurethral resection in 941 patients with non-muscle-invasive bladder cancer. BJU Int. 2018. PMID: 29319922. doi:10.1111/bju.14124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。